What are the acute causes of elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT)?

Acute Causes of Elevated AST and ALT

The most common acute causes of markedly elevated aminotransferases are ischemic hepatitis (accounting for 33-44% of cases), drug-induced liver injury (particularly acetaminophen), acute viral hepatitis, and acute biliary obstruction from choledocholithiasis. 1, 2, 3

Understanding the Pattern and Severity

The degree of aminotransferase elevation provides critical diagnostic clues:

• Mild elevation (<5× upper limit): Most commonly NAFLD or alcohol-induced liver disease
• Moderate elevation (5-10× upper limit): Consider viral hepatitis, drug injury, or autoimmune causes
• Severe elevation (>10× upper limit): Strongly suggests acute ischemic hepatitis, acute drug toxicity, or acute viral hepatitis 1

Key Diagnostic Distinction: AST vs ALT Predominance

ALT is more specific for hepatocellular injury since it has low concentrations in skeletal muscle and kidney, while AST can be elevated from cardiac muscle, skeletal muscle, kidneys, brain, and red blood cells 1. If AST predominates over ALT, you must consider non-hepatic causes including hemolysis, myopathy, thyroid disease, and strenuous exercise 1.

The AST:ALT ratio >2 suggests alcohol-induced liver disease, while a ratio <1 points toward metabolic/NAFLD causes 1.

Specific Acute Causes by Category

Hepatocellular Injury Causes

Ischemic Hepatitis (Shock Liver)

• Accounts for 33-44% of markedly elevated aminotransferases 2, 3, 4
• Carries the highest mortality (35-44% at 30 days) 2, 3, 4
• Look for: hypotension, cardiogenic or septic shock, COPD, CHF, coronary artery disease, metabolic acidosis 3
• Typically shows GGT <135 IU/L and albumin <34 g/L 3

Drug-Induced Liver Injury (DILI)

• Represents 11-19% of acute severe elevations 2, 4, 5
• Acetaminophen is the most common culprit
• Must obtain detailed medication history including over-the-counter drugs, vitamins, and herbal supplements 6
• 7% liver-related mortality 4

Acute Viral Hepatitis

• Accounts for 7-11% of cases 2, 4, 5
• Test for: HAV-IgM, HBsAg, HBc-IgM, HCV antibody (consider HCV-RNA) 6
• Don't miss hepatitis E - requires specific testing and has high index of suspicion 5

Acute Biliary Obstruction

• Choledocholithiasis is the most common cause (34% in one series) 4
• Can present with ALT >1000 IU/L despite being primarily cholestatic 4, 5
• Requires urgent imaging (ultrasound first-line) 1

Other Critical Acute Causes

Acute Budd-Chiari Syndrome - vascular outflow obstruction 1

Autoimmune Hepatitis - rare but important acute presentation 1

Acute Wilson Disease - consider in younger patients 1

Acute Hemochromatosis - uncommon acute presentation 1

Non-Hepatic Causes of Elevated AST

When AST is disproportionately elevated compared to ALT, consider 7:

• Skeletal muscle damage (54% of non-hepatic causes): rhabdomyolysis, trauma, strenuous exercise
• Cardiac muscle damage (39%): myocardial infarction, myocarditis
• Hematologic disorders (7%): hemolysis, but carries 65% 30-day mortality 7

Critical Prognostic Factors

Peak aminotransferase level directly correlates with mortality 2, 7, 3:

• AST <1000 IU/L: 12.8% mortality
• AST 1000-3000 IU/L: 26.7% mortality
• AST ≥3000 IU/L: 50% mortality 7

Independent predictors of 30-day mortality include 3:

• Septic shock (OR 14.7)
• Metabolic acidosis (OR 7.3)
• COPD history (OR 5.4)
• Cardiogenic shock (OR 4.3)
• PT ≥20 seconds (OR 3.7)
• Age ≥65 years (OR 3.0)

Initial Diagnostic Approach

Immediately obtain 6, 1:

1. Detailed medication/supplement history (including herbals, OTC drugs)
2. Alcohol consumption assessment
3. Risk factors for viral hepatitis
4. Hemodynamic status and evidence of shock
5. Complete metabolic panel including bilirubin, alkaline phosphatase, albumin, PT/INR

First-line serologic testing 6:

• Hepatitis A IgM, HBsAg, HBc-IgM, HCV antibody
• Consider acetaminophen level if any suspicion of ingestion

First-line imaging: Abdominal ultrasound to evaluate for biliary obstruction and hepatic steatosis 1

Common Pitfalls

• Missing hepatitis E: Not included in standard viral hepatitis panels - requires specific testing 5
• Overlooking choledocholithiasis: Can cause ALT >1000 IU/L despite being primarily cholestatic 4, 5
• Assuming all elevated AST is hepatic: Always consider cardiac, skeletal muscle, and hematologic sources when AST predominates 1, 7
• Failing to identify ischemic hepatitis: Carries 35-44% mortality and requires recognition of underlying shock state 2, 3, 4
• Not finding a cause has poor prognosis: 6% of cases remain unexplained and this carries worse outcomes 4, 5

If markedly elevated aminotransferases persist, show evidence of chronic liver disease, or are accompanied by abnormal albumin/PT, expedite complete evaluation including potential liver biopsy 6.